MIMRYLO Solution for injection Ref.[116914] Active ingredients: Rusfertide

Source: FDA, National Drug Code (US)  Revision Year: 2026 

Product description

MIMRYLO (rusfertide) for injection, for subcutaneous use, a hepcidin mimetic, is a synthetic cyclic peptide (disulfide) isolated as an acetate salt. The chemical name for rusfertide is S 6,S 16cyclo[N-isovaleryl-Asp-Thr-His-Phe-Pro-Cys-Ile-(N-palmitoyl-γ-Glu)-Lys-Phe-Glu-Pro-Arg-Ser-Lys-Gly-Cys-Lys-NH2] acetate.

Rusfertide acetate has the following chemical structure:

Rusfertide acetate is an amorphous white to off-white powder, light sensitive and hygroscopic with low solubility in ethanol or acetonitrile. The aqueous solubility in pH range of 2.5 to 7.4 is ≥112 mg/mL.

The average molecular weight for the free base is 2442.0 u. The molecular formula for the free base is C114H181N27O28S2.

MIMRYLO for injection is supplied as a sterile, preservative-free, white to off-white lyophilized powder in a single-dose glass vial. The 9.5 mg dose strength delivers 9.5 mg of rusfertide (provided as rusfertide acetate), mannitol (25 mg), sodium acetate trihydrate (1.36 mg), and glacial acetic acid/sodium hydroxide for pH adjustment, for subcutaneous injection after reconstitution with the provided diluent. The 19 mg, 28 mg, 41 mg, and 54 mg dose strengths deliver 19 mg, 28 mg, 41 mg and 54 mg of rusfertide (provided as rusfertide acetate), mannitol (20 mg), sodium acetate trihydrate (1.36 mg), and glacial acetic acid/sodium hydroxide for pH adjustment, for subcutaneous injection after reconstitution with the provided diluent.

The diluent for MIMRYLO is a sterile, preservative-free solution containing sodium acetate trihydrate (1.36 mg/mL), zinc acetate dihydrate (2.2 mg/mL), and glacial acetic acid for adjusting the pH to nominal pH of 5.4 in Water for Injection, USP. It is a clear, colorless solution, free from visible particles, and is provided in a glass prefilled syringe.

After reconstitution, MIMRYLO is a clear and colorless solution free from visible particles.

Dosage Forms and Strengths

For injection: a sterile, white to off-white lyophilized powder for reconstitution in single-dose vials containing 9.5 mg, 19 mg, 28 mg, 41 mg, and 54 mg rusfertide (provided as rusfertide acetate) per vial, co-packaged with a clear diluent solution.

How Supplied

MIMRYLO for injection is supplied in a carton for each individual dosage strength comprising a single-dose vial containing a sterile, preservative-free, white to off-white lyophilized powder and a single-dose prefilled syringe containing a clear, colorless solution (diluent) with a luer lock adapter and soft inner tip cap.

Not made with natural rubber latex.

Dosage
Strength
(mg/vial)
Color Cap
Indicator
Vial NDC
Number
Carton NDC
Number
9.5Blue63020-710-1063020-715-10
19Lime63020-720-2063020-725-20
28Burgundy63020-730-3063020-735-30
41Yellow63020-740-4063020-745-40
54White63020-760-6063020-765-60

Prefilled Diluent Syringe NDC 63020-600-05

Distributed by: Takeda Pharmaceuticals America, Inc., Cambridge, MA 02142

Drugs

Drug Countries
MIMRYLO United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.